810222P

C6-NBD Glucosyl Ceramide

Avanti Research^™ - A Croda Brand 810222P, powder

• 别名: N-[6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl]-D-glucosyl-β1-1′-sphingosine
• 经验公式（希尔记法）: C₃₆H₅₉N₅O₁₁
• CAS号: 94885-03-7
• 分子量: 737.88
• 分類程式碼代碼: 12352211
• NACRES: NA.25

属性

• 化驗: >99% (TLC)
• 形狀: powder
• 包裝: pkg of 1 × 1 mg (810222P-1MG); pkg of 1 × 250 μg (810222P-250ug)
• 製造商／商標名: Avanti Research^™ - A Croda Brand 810222P
• 運輸包裝: dry ice
• 儲存溫度: −20°C

说明

生化／生理作用

The synthesis of glucosyl ceramide (GlcCer) occurs in the cytosolic membranes of Golgi. It is catalysed by GlcCer synthase. In the luminal Golgi membrane, GlcCer participates in the generation of glycosphingolipids. C6-NBD glcCer is useful to view ceramide rich membrane domains in Golgi compartments.

包裝

5 mL Amber Glass Screw Cap Vial (810299P-1MG)

5 mL Clear Glass Sealed Ampule (810222P-250ug)

法律資訊

Avanti Research is a trademark of Avanti Polar Lipids, LLC

安全信息

• 儲存類別代碼: 11 - Combustible Solids
• 水污染物質分類（WGK）: WGK 3
• 閃點（°F）: No data available
• 閃點（°C）: No data available